Results 41 to 50 of about 4,996,320 (179)

Differential characteristics among asymptomatic and symptomatic meibomian gland dysfunction and those with dry eye

open access: yesBMC Ophthalmology, 2023
Purpose To identify the characteristics of asymptomatic meibomian gland dysfunction (MGD), symptomatic MGD, and MGD coexisting with dry eye disease (DED). Methods This cross sectional study enrolled a total of 153 eyes of 87 MGD patients.
Yi-Ran Chiou   +4 more
doaj   +1 more source

Budget impact analysis (BIA) of the TearCare System for the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED) in the United States (US)

open access: yesExpert Review of Ophthalmology
TearCare is an in-office procedure indicated to restore MGD and relieve DED signs and symptoms. MGD is a major cause of DED, a high prevalence condition currently treated with medical therapies including over-the-counter and prescription drops. The BIA assessed the budget impact of increasing the TearCare market share against prescription drops in ...
Thomas Chester   +5 more
openaire   +1 more source

Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling

open access: yesComprehensive Physiology, Volume 16, Issue 5, October 2026.
Short‐chain fatty acids generated by gut microbial fermentation link diet to ocular physiology via the gut–eye axis. Through systemic distribution, these metabolites regulate GPCR signaling, epigenetic pathways, inflammation, and angiogenesis, shaping retinal homeostasis and highlighting therapeutic potential in ocular vascular and inflammatory ...
Aleah J. Brokemond   +6 more
wiley   +1 more source

Diagnostic Test Efficacy of Meibomian Gland Morphology and Function [PDF]

open access: yes, 2019
Meibomian gland dysfunction (MGD) is the leading cause of dry eye and proposed treatments are based on disease severity. Our purpose was to establish reliable morphologic measurements of meibomian glands for evaluating MGD severity.
Utheim, Tor P.,   +22 more
core   +1 more source

Compounded 0.03% Tacrolimus in Cross‐Linked Hyaluronate Improves Ocular Surface Health in Dogs With Evaporative Dry Eye Disease

open access: yesVeterinary Ophthalmology, Volume 29, Issue 5, September 2026.
ABSTRACT Objective To assess the clinical effects of a compounded 0.03% tacrolimus in 0.75% cross‐linked hyaluronic acid (XHA) on tear quantity, quality, and ocular surface health in dogs with evaporative dry eye disease (EDED). Procedures Sixteen client‐owned dogs diagnosed with EDED (normal aqueous production yet reduced stability) were enrolled in ...
Lionel Sebbag   +4 more
wiley   +1 more source

Statistical Comparison of four Groups: Healthy, Aqueous Tear Deficiency (ATD), obvious obstructive Meibomian Gland Dysfunction (MGD), and Non-obvious Obstructive MGD (NOMGD) Patients.

open access: yes, 2014
* Average ± standard deviation.†Median (mode) ± Average Absolute deviation. Mode was added if different from the median.OSDI  =  Ocular Surface Disease ndex; FBUT  =  fluorescein break-up time; FSOS  =  fluorescein staining of the ocular surface;SVST  = 
Giovanni Maria Satta (654619)   +3 more
core   +1 more source

Common Ophthalmic Conditions in Popular Dog Breeds in Japan: Insights From a Survey of 105 Veterinarians Practicing Ophthalmology

open access: yesVeterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Objective To identify commonly presented dog breeds and potentially heritable ophthalmic diseases encountered by veterinarians practicing ophthalmology in Japan. Methods A survey was distributed through the Japanese Society of Comparative and Veterinary Ophthalmology.
Victoria Caballero   +8 more
wiley   +1 more source

Intense pulsed light plus meibomian gland expression versus intense pulsed light alone for meibomian gland dysfunction: A randomized crossover study.

open access: yes, 2021
PurposeTo investigate the comparative efficacy of intense pulsed light (IPL) therapy alone with that of IPL plus meibomian gland expression (MGX) for meibomian gland dysfunction (MGD).MethodsThis is a prospective randomized crossover clinical trial ...
Chan Hee Moon   +4 more
core   +1 more source

Outcome parameters in studies investigating dry eye disease: A systematic literature review

open access: yesActa Ophthalmologica, Volume 104, Issue 4, Page e363-e372, June 2026.
Abstract The development of effective therapeutics for dry eye disease (DED) is challenging due to its complex pathophysiology, heterogeneous patient presentation and the significant failure rate of previous clinical development programs. This underlines the importance of the selection of appropriate endpoints for clinical trials.
Viktoria Pai   +8 more
wiley   +1 more source

A clinical study of thunder-fire moxibustion combined with meibomian gland massage in treatment of meibomian gand dysfunction

open access: yes针刺研究, 2022
Objective To observe the effect of thunder-fire moxibustion combined with meibomian gland massage in improving meibomian gland dysfunction(MGD) and explore its mechanism.
QIAN Li-jun   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy